Osmotic agents play a vital role in the reduction of elevated intracranial pressure and treatment of cerebral edema in Neurologic critical care. Both mannitol and hypertonic saline reduce cerebral edema in many clinical syndromes, yet there is controversy over agent selection, timing, and dosing regimens. Despite the lack of randomized, controlled trials, our knowledge base on the appropriate clinical use of osmotic agents continues to expand. This review will summarize the evidence for the use of mannitol and hypertonic saline in a variety of disease states causing cerebral edema, as well as outlining monitoring and safety considerations.
JavidMSettlageP.
Effect of urea on cerebrospinal fluid pressure in human subjects; preliminary report. J Am Med Assoc. 171956;160(11):943–949
2.
CantoreGGuidettiBVirnoM. Oral glycerol for the reduction of intracranial pressure. J Neurosurg. 1964;21:278–283.
3.
HemmerR.
Comparative studies on the drug-induced decrease in cerebral pressure. Med Klin. 20, 1961;56:105–108
4.
WiseBLChaterN. The value of hypertonic mannitol solution in decreasing brain mass and lowering cerebro-spinal-fluid pressure. J Neurosurg. 1962;19:1038–1043.
5.
BurkeAMQuestDOChienSCerriC. The effects of mannitol on blood viscosity. J Neurosurg. 1981;55(4):550–553.
6.
WillersonJTWatsonJTHuttonIFixlerDECurryGCTempletonGH. The influence of hypertonic mannitol on regional myocardial blood flow during acute and chronic myocardial ischemia in anesthetized and awake intact dogs. J Clin Invest. 1975;55(5):892–902.
7.
MuizelaarJPLutzHA 3rdBeckerDP. Effect of mannitol on ICP and CBF and correlation with pressure autoregulation in severely head-injured patients. J Neurosurg. 1984;61(4):700–706.
8.
WisnerDHSchusterLQuinnC. Hypertonic saline resuscitation of head injury: effects on cerebral water content. J Trauma. Jan 1990;30(1):75–78.
9.
MannoEMAdamsREDerdeynCPPowersWJDiringerMN. The effects of mannitol on cerebral edema after large hemispheric cerebral infarct. Neurology. Feb 1999;52(3):583–587.
10.
PaczynskiRPHeYYDiringerMNHsuCY. Multiple-dose mannitol reduces brain water content in a rat model of cortical infarction. Stroke. 1997;28(7):1437–1443.discussion 1444
11.
VideenTOZazuliaARMannoEM. Mannitol bolus preferentially shrinks non-infarcted brain in patients with ischemic stroke. Neurology. 11 2001;57(11):2120–2122.
12.
BrattonSLChestnutRMGhajarJ. Guidelines for the management of severe traumatic brain injury. II. Hyperosmolar therapy. J Neurotrauma. 2007;24(Suppl 1):S14–S20.
13.
OkenDE. Renal and extrarenal considerations in high-dose mannitol therapy. Ren Fail. 1994;16(1):147–159.
14.
VassarMJFischerRPO'BrienPE. A multicenter trial for resuscitation of injured patients with 7.5% sodium chloride. The effect of added dextran 70. The Multicenter Group for the Study of Hypertonic Saline in Trauma Patients. Arch Surg. 1993;128(9):1003–1011.; discussion 1011-1003
15.
WadeCEGradyJJKramerGCYounesRNGehlsenKHolcroftJW. Individual patient cohort analysis of the efficacy of hypertonic saline/dextran in patients with traumatic brain injury and hypotension. J Trauma. 1997;42(suppl 5):S61–S65.
16.
AndersonJTWisnerDHSullivanPE. Initial small-volume hypertonic resuscitation of shock and brain injury: short- and long-term effects. J Trauma. 1997;42(4):592–600.; discussion 600-591
17.
BacherAWeiJGrafeMRQuastMJZornowMH. Serial determinations of cerebral water content by magnetic resonance imaging after an infusion of hypertonic saline. Crit Care Med. 1998;26(1):108–114.
18.
ProughDSWhitleyJMTaylorCLDealDDDeWittDS. Regional cerebral blood flow following resuscitation from hemorrhagic shock with hypertonic saline. Influence of a subdural mass. Anesthesiology. 1991;75(2):319–327.
19.
SchmokerJDZhuangJShackfordSR. Hypertonic fluid resuscitation improves cerebral oxygen delivery and reduces intracranial pressure after hemorrhagic shock. J Trauma. 1991;31(12):1607–1613.
FroelichMNiQWessCOugoretsIHartlR. Continuous hypertonic saline therapy and the occurrence of complications in neurocritically ill patients. Crit Care Med. 2009;37(4):1433–1441.
22.
QureshiAISuarezJICastroABhardwajA. Use of hypertonic saline/acetate infusion in treatment of cerebral edema in patients with head trauma: experience at a single center. J Trauma. 1999;47(4):659–665.
23.
IchaiCArmandoGOrbanJC. Sodium lactate versus mannitol in the treatment of intracranial hypertensive episodes in severe traumatic brain-injured patients. Intensive Care Med. 2009;35(3):471–479.
24.
FranconyGFauvageBFalconD. Equimolar doses of mannitol and hypertonic saline in the treatment of increased intracranial pressure. Crit Care Med. 2008;36(3):795–800.
25.
BattisonCAndrewsPJGrahamCPettyT.
Randomized, controlled trial on the effect of a 20% mannitol solution and a 7.5% saline/6% dextran solution on increased intracranial pressure after brain injury. Crit Care Med. Jan2005;33(1):196–202; discussion 257-198.
26.
HarutjunyanLHolzCRiegerAMenzelMGrondSSoukupJ.
Efficiency of 7.2% hypertonic saline hydroxyethyl starch 200/0.5 versus mannitol 15% in the treatment of increased intracranial pressure in neurosurgical patients - a randomized clinical trial [ISRCTN62699180]. Crit Care. Oct 52005;9(5):R530–540.
27.
VialetRAlbaneseJThomachotL. Isovolume hypertonic solutes (sodium chloride or mannitol) in the treatment of refractory posttraumatic intracranial hypertension: 2 mL/kg 7.5% saline is more effective than 2 mL/kg 20% mannitol. Crit Care Med. 2003;31(6):1683–1687.
28.
KerwinAJSchincoMATepasJJ 3rdRenfroWHVitarboEAMuehlbergerM. The use of 23.4% hypertonic saline for the management of elevated intracranial pressure in patients with severe traumatic brain injury: a pilot study. J Trauma. 2009;67(2):277–282.
29.
JamesHE. Methodology for the control of intracranial pressure with hypertonic mannitol. Acta Neurochir (Wien). 1980;51(3-4):161–172.
30.
BeckerDP. The alleviation of increased intracranial pressure by the chronic adminitration of osmotic agents. Berlin: Springer; 1972.
31.
MendelowADTeasdaleGMRussellTFloodJPattersonJMurrayGD. Effect of mannitol on cerebral blood flow and cerebral perfusion pressure in human head injury. J Neurosurg. 1985;63(1):43–48.
32.
QureshiAISuarezJIBhardwajA. Use of hypertonic (3%) saline/acetate infusion in the treatment of cerebral edema: effect on intracranial pressure and lateral displacement of the brain. Crit Care Med. 1998;26(3):440–446.
33.
HornPMunchEVajkoczyP. Hypertonic saline solution for control of elevated intracranial pressure in patients with exhausted response to mannitol and barbiturates. Neurol Res. 1999;21(8):758–764.
34.
MunarFFerrerAMde NadalM. Cerebral hemodynamic effects of 7.2% hypertonic saline in patients with head injury and raised intracranial pressure. J Neurotrauma. 2000;17(1):41–51.
35.
SchatzmannCHeisslerHEKonigK. Treatment of elevated intracranial pressure by infusions of 10% saline in severely head injured patients. Acta Neurochir Suppl. 1998;71:31–33.
36.
WhiteHCookDVenkateshB. The use of hypertonic saline for treating intracranial hypertension after traumatic brain injury. Anesth Analg. 2006;102(6):1836–1846.
37.
WareMLNemaniVMMeekerMLeeCMorabitoDJManleyGT. Effects of 23.4% sodium chloride solution in reducing intracranial pressure in patients with traumatic brain injury: a preliminary study. Neurosurgery. 2005;57(4):727–736.; discussion 727-736
38.
OddoMLevineJMFrangosS. Effect of mannitol and hypertonic saline on cerebral oxygenation in patients with severe traumatic brain injury and refractory intracranial hypertension. J Neurol Neurosurg Psychiatry. 2009;80(8):916–920.
39.
BakerAJRhindSGMorrisonLJ. Resuscitation with hypertonic saline-dextran reduces serum biomarker levels and correlates with outcome in severe traumatic brain injury patients. J Neurotrauma. 2009;26(8):1227–1240.
40.
Guidelines for the management of severe traumatic brain injury. J Neurotrauma. 2007;24(suppl 1):S1–S106.
41.
KaufmannAMCardosoER. Aggravation of vasogenic cerebral edema by multiple-dose mannitol. J Neurosurg. 1992;77(4):584–589.
42.
BereczkiDMihalkaLSzatmariS. Mannitol use in acute stroke: case fatality at 30 days and 1 year. Stroke. 2003;34(7):1730–1735.
43.
SchwarzSSchwabSBertramMAschoffAHackeW. Effects of hypertonic saline hydroxyethyl starch solution and mannitol in patients with increased intracranial pressure after stroke. Stroke. 1998;29(8):1550–1555.
44.
SchwarzSGeorgiadisDAschoffASchwabS. Effects of hypertonic (10%) saline in patients with raised intracranial pressure after stroke. Stroke. 2002;33(1):136–140.
45.
BhardwajAHarukuniIMurphySJ. Hypertonic saline worsens infarct volume after transient focal ischemia in rats. Stroke. 2000;31(7):1694–1701.
46.
AdamsHPJrdel ZoppoGAlbertsMJ. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke. 2007;38(5):1655–1711.
47.
BermuellerCThalSCPlesnilaNSchmid-ElsaesserRKreimeierUZausingerS. Hypertonic fluid resuscitation from subarachnoid hemorrhage in rats: a comparison between small volume resuscitation and mannitol. J Neurol Sci. Feb 152006;241(1-2):73–82.
48.
ZausingerSThalSCKreimeierUMessmerKSchmid-ElsaesserR. Hypertonic fluid resuscitation from subarachnoid hemorrhage in rats. Neurosurgery. 2004;55(3):679–686.discussion 686-677
49.
BentsenGBreivikHLundarTStubhaugA. Hypertonic saline (7.2%) in 6% hydroxyethyl starch reduces intracranial pressure and improves hemodynamics in a placebo-controlled study involving stable patients with subarachnoid hemorrhage. Crit Care Med. 2006;34(12):2912–2917.
50.
TsengMYAl-RawiPGCzosnykaM. Enhancement of cerebral blood flow using systemic hypertonic saline therapy improves outcome in patients with poor-grade spontaneous subarachnoid hemorrhage. J Neurosurg. 2007;107(2):274–282.
51.
MisraUKKalitaJRanjanPMandalSK. Mannitol in intracerebral hemorrhage: a randomized controlled study. J Neurol Sci. 15 2005;234(1-2):41–45.
52.
KalitaJMisraUKRanjanPPradhanPKDasBK. Effect of mannitol on regional cerebral blood flow in patients with intracerebral hemorrhage. J Neurol Sci. 15, 2004;224(1-2):19–22.
53.
QureshiAIWilsonDATraystmanRJ. Treatment of transtentorial herniation unresponsive to hyperventilation using hypertonic saline in dogs: effect on cerebral blood flow and metabolism. J Neurosurg Anesthesiol. 2002;14(1):22–30.
54.
QureshiAIWilsonDATraystmanRJ. Treatment of elevated intracranial pressure in experimental intracerebral hemorrhage: comparison between mannitol and hypertonic saline. Neurosurgery. 1999;44(5):1055–1063.; discussion 1063-1054
55.
JalanR. Pathophysiological basis of therapy of raised intracranial pressure in acute liver failure. Neurochem Int. 2005;47(1-2):78–83.
56.
BleiAT. The pathophysiology of brain edema in acute liver failure. Neurochem Int. 2005;47(1-2):71–77.
57.
CanaleseJGimsonAEDavisCMellonPJDavisMWilliamsR. Controlled trial of dexamethasone and mannitol for the cerebral oedema of fulminant hepatic failure. Gut. 1982;23(7):625–629.
58.
MurphyNAuzingerGBernelWWendonJ. The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure. Hepatology. 2004;39(2):464–470.
59.
QureshiAIGeocadinRGSuarezJIUlatowskiJA. Long-term outcome after medical reversal of transtentorial herniation in patients with supratentorial mass lesions. Crit Care Med. 2000;28(5):1556–1564.
60.
KoenigMABryanMLewinJL3rdMirskiMAGeocadinRGStevensRD.
Reversal of transtentorial herniation with hypertonic saline. Neurology. 252008;70(13):1023–1029
61.
RosnerMHRoncoC. Dysnatremias in the intensive care unit. Contrib Nephrol. 2010;165:292–298.
62.
DiringerMNZazuliaAR. Osmotic therapy: fact and fiction. Neurocrit Care. 2004;1(2):219–233.
63.
BeckerDVriesJ. The Alleviation of Increased Intracranial Pressure by the Chronic Administration of Osmotic Agents. New York: Springer; 1972.
64.
AiyagariVDeibertEDiringerMN. Hypernatremia in the neurologic intensive care unit: how high is too high?. J Crit Care. 2006;21(2):163–172.
65.
CloydJCSnyderBDCleeremansBBundlieSRBlomquistCHLakatuaDJ. Mannitol pharmacokinetics and serum osmolality in dogs and humans. J Pharmacol Exp Ther. 1986;236(2):301–306.
66.
Garcia-MoralesEJCariappaRParvinCAScottMGDiringerMN. Osmole gap in neurologic-neurosurgical intensive care unit: Its normal value, calculation, and relationship with mannitol serum concentrations. Crit Care Med. 2004;32(4):986–991.
67.
RabetoyGMFredericksMRHostettlerCF. Where the kidney is concerned, how much mannitol is too much?. Ann Pharmacother. 1993;27(1):25–28.
68.
TemesSPLilienOMChamberlainW. A direct vasoconstrictor effect of mannitol on the renal artery. Surg Gynecol Obstet. 1975;141(2):223–226.
69.
WhelanTVBaconMEMaddenMPatelTGHandyR. Acute renal failure associated with mannitol intoxication. Report of a case. Arch Intern Med. 1984;144(10):2053–2055.
70.
DormanHRSondheimerJHCadnapaphornchaiP. Mannitol-induced acute renal failure. Medicine (Baltimore). 1990;69(3):153–159.
71.
HuangPPStuckyFSDimickARTreatRCBesseyPQRueLW. Hypertonic sodium resuscitation is associated with renal failure and death. Ann Surg. 1995;221(5):543–554.; discussion 554-547
72.
KhannaSDavisDPetersonB. Use of hypertonic saline in the treatment of severe refractory posttraumatic intracranial hypertension in pediatric traumatic brain injury. Crit Care Med. 2000;28(4):1144–1151.
73.
PetersonBKhannaSFisherBMarshallL. Prolonged hypernatremia controls elevated intracranial pressure in head-injured pediatric patients. Crit Care Med. 2000;28(4):1136–1143.
74.
KrausMA. Selection of dialysate and replacement fluids and management of electrolyte and Acid-base disturbances. Semin Dial. Mar-2009;22(2):137–140.
75.
NauR. Osmotherapy for elevated intracranial pressure: a critical reappraisal. Clin Pharmacokinet. 2000;38(1):23–40.
76.
ForsythLLLiu-DeRykeXParkerDJrRhoneyDH. Role of hypertonic saline for the management of intracranial hypertension after stroke and traumatic brain injury. Pharmacotherapy. 2008;28(4):469–484.
